KDM6B and inflammatory bowel disease: Treatment with a JMJD3 inhibitor significantly alleviated intestinal inflammation and decreased inflammatory factor expression in the mouse colon, implicating an inflammatory role of JMJD3 in IBD [28, 64, 65].